Prefilled / Single-Use Platform
. The Prefilled / Single-Use Platform is designed to support ready-to-use needle-free delivery in scenarios where simplicity, speed, and execution reliability are critical.
. By integrating the drug into a prefilled, single-use configuration, this platform reduces preparation steps and user decision points—supporting intuitive administration across home, on-the-go, and time-sensitive use environments. It provides a practical execution pathway for pharmaceutical programs seeking to extend injectable therapies beyond controlled clinical settings while maintaining delivery consistency and safety.
This platform category is commonly evaluated for programs prioritizing ease of use, emergency readiness, and broad real-world accessibility, particularly where user variability and context diversity are key considerations.
Typical Use Scenarios & Program Fit
Home & Self-Managed Administration
Often evaluated for therapies intended for home use, self-care, or caregiver-assisted administration.
Single-use, prefilled formats reduce operational complexity and training requirements, supporting consistent execution outside clinical supervision.
On-the-Go & Real-World Use Contexts For programs where patients may need to carry medication during travel, daily activities, or outdoor settings, this platform supports compact, ready-to-use delivery without ancillary components or preparation steps.
Emergency & Time-Critical Treatment
Commonly considered for emergency or rescue medications where speed, reliability, and low cognitive load are essential (e.g., acute allergic reactions).
Immediate usability supports timely administration under high-stress conditions.
Programs Prioritizing Operational Simplicity When reducing use errors, simplifying logistics, or minimizing user variability is a primary objective, the Prefilled / Single-Use Platform offers a streamlined delivery approach aligned with real-world execution needs.
Development & Evaluation Workflow
Programs typically engage the Prefilled / Single-Use Platform through a structured, project-specific evaluation process:
Initial Program Discussion Alignment on intended use environment, user profile, dosing needs, and lifecycle objectives.
Prefilled System Configuration Definition of delivery parameters and single-use system architecture aligned with drug characteristics and use context.
Usability-Focused Evaluation Representative use evaluations and bench testing to assess delivery reliability, user interaction, and execution robustness across realistic scenarios.
Execution Pathway Definition
Definition of an execution pathway supporting clinical use, emergency preparedness, or deployment in non-controlled environments.
Technical Fit Boundaries
. Designed for liquid injectable drugs integrated into prefilled, single-use containers
. Supports single-dose administration with minimal preparation steps
. Applicable across intradermal (ID), subcutaneous (SC), or intramuscular (IM) routes, depending on configuration
. Does not alter drug substance or formulation strategy; the delivery system is adapted around the drug
Platform Scope & Next Step
This platform category provides a ready-to-use execution pathway for evaluating needle-free delivery in real-world and time-critical use scenarios.
It is not a predefined product configuration; system design and execution details are defined based on individual program requirements and intended use environments.
If this platform category appears relevant to your program, we welcome a confidential discussion to assess project-specific fit and development pathways.
Extractable / Fill-on-Demand Platform
The Extractable / Fill-on-Demand Platform is designed as a universal needle-free delivery architecture, enabling rapid evaluation and execution across a broad range of injectable drugs and development stages.
By allowing drug withdrawal directly from vials, ampoules, or cartridges at the point of use, this platform decouples delivery system exploration from early container or format decisions. It provides pharmaceutical teams with maximum flexibility to assess needle-free feasibility while preserving freedom to transition into other platform formats as programs mature.
This platform category is commonly evaluated when universality, speed, and cross-program adaptability are strategic priorities—particularly in early development, clinical transition, and globally diversified portfolios.
Pen-Type / Cartridge-Based Platform
. The Pen-Type / Cartridge-Based Platform is designed to enable a direct transition from existing cartridge-based injectable formats to needle-free delivery.
. By retaining established cartridge containers and upgrading the delivery mechanism at the device level, this platform allows pharmaceutical teams to explore needle-free execution while preserving drug substance, formulation, and core CMC strategies. It offers a familiar, execution-ready pathway for format innovation with minimal disruption.
This platform category is commonly evaluated in the context of lifecycle management, patient-centric delivery upgrades, and cartridge-based program expansion, where continuity of primary packaging and manufacturing logic is a priority.
